Vital KSK Holdings, Inc.

3151.T
Medical Distribution
2026/07/27 Updated
Market Cap: $493.1M (¥80.7B)
Stock Price: $10.26 (¥1,680)
Exchange Rate: 1 USD = ¥163.67

Notice of Recording of Investment Securities Sale Profit | July 2026

Our two consolidated subsidiaries have sold listed stocks they hold, recording an investment securities sale profit of 8,100 million yen. The reason for the sale is asset optimization and strengthening of financial health. There is no change to the earnings forecast for the upcoming period.

Importance:
Page Updated: July 27, 2026
IR Disclosure Date: July 27, 2026

Key Figures

  • Investment securities sale profit: 8,100 million yen
  • Sale period: July 28, 2026 – March 31, 2027
  • Impact on current consolidated earnings forecast: None

AI要約

Sale of Investment Securities and Recording of Extraordinary Profit

Vital K.S.K. Holdings Corporation has resolved to sell part of the listed stocks held by its two consolidated subsidiaries, recording an investment securities sale profit of 8,100 million yen. The background of the sale includes review of policy-holding stocks, asset optimization, and strengthening of financial health. The sale period is from July 28, 2026, to March 31, 2027, with no impact on the current consolidated earnings forecast.

Future Outlook and Impact on Shareholders

Currently, there is no change to the consolidated earnings forecast for the fiscal year ending March 2027, and if revisions become necessary, they will be promptly announced. The recording of sale profit aims to improve financial soundness and asset efficiency, potentially having a positive impact on future business strategies and financial conditions. Investors should view this as part of asset review and financial strengthening efforts.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Vital K.S.K. Holdings Corporation

Company overview · Stock price · Financial data · All IR

View company page →